COMPARATIVE IN-VITRO STUDY OF IMMEDIATE AND MODIFIED RELEASED ORAL DOSAGE FORMS OF CEFACLOR
暂无分享,去创建一个
C. Davila | Miron Dalia Simona | B. D. George | Traian Alexandru | Baloescu Corneliu | Mitu Mirela Adriana | Popa Daniela Elena
[1] J. Crison,et al. Biowaiver approach for biopharmaceutics classification system class 3 compound metformin hydrochloride using in silico modeling. , 2012, Journal of pharmaceutical sciences.
[2] I. Homšek,et al. Influence of Dissolution Media Composition on Cefaclor Release form Capsules , 2010 .
[3] M. Al-Ghazawi,et al. Development of a predictive in vitro dissolution for clarithromycin granular suspension based on in vitro-in vivo correlations , 2009, Pharmaceutical development and technology.
[4] A. Hussain,et al. A Modern View of Excipient Effects on Bioequivalence: Case Study of Sorbitol , 2006, Pharmaceutical Research.
[5] P. Costa,et al. Modeling and comparison of dissolution profiles. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[6] B. Schug,et al. The biopharmaceutics classification system (BCS): class III drugs - better candidates for BA/BE waiver? , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[7] P. Cole. Pharmacologic and clinical comparison of cefaclor in immediate-release capsule and extended-release tablet forms. , 1997, Clinical therapeutics.
[8] J. M. Hoover,et al. Effects of sinker shapes on dissolution profiles. , 1989, Journal of pharmaceutical sciences.
[9] K. A. Khan. The concept of dissolution efficiency , 1975, The Journal of pharmacy and pharmacology.